LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 29

Search options

  1. Article ; Online: Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.

    Eken, Janneke A / Koning, Marvyn T / Kupcova, Kristyna / Sepúlveda Yáñez, Julieta H / de Groen, Ruben A L / Quinten, Edwin / Janssen, Jurriaan / van Bergen, Cornelis A M / Vermaat, Joost S P / Cleven, Arjen / Navarrete, Marcelo A / Ylstra, Bauke / de Jong, Daphne / Havranek, Ondrej / Jumaa, Hassan / Veelken, Hendrik

    The Journal of experimental medicine

    2024  Volume 221, Issue 5

    Abstract: Diffuse large B cell lymphoma of activated B cell type (ABC-DLBCL), a major cell-of-origin DLBCL subtype, is characterized by chronic active B cell receptor (BCR) signaling and NF-κB activation, which can be explained by activating mutations of the BCR ... ...

    Abstract Diffuse large B cell lymphoma of activated B cell type (ABC-DLBCL), a major cell-of-origin DLBCL subtype, is characterized by chronic active B cell receptor (BCR) signaling and NF-κB activation, which can be explained by activating mutations of the BCR signaling cascade in a minority of cases. We demonstrate that autonomous BCR signaling, akin to its essential pathogenetic role in chronic lymphocytic leukemia (CLL), can explain chronic active BCR signaling in ABC-DLBCL. 13 of 18 tested DLBCL-derived BCR, including 12 cases selected for expression of IgM, induced spontaneous calcium flux and increased phosphorylation of the BCR signaling cascade in murine triple knockout pre-B cells without antigenic stimulation or external BCR crosslinking. Autonomous BCR signaling was associated with IgM isotype, dependent on somatic BCR mutations and individual HCDR3 sequences, and largely restricted to non-GCB DLBCL. Autonomous BCR signaling represents a novel immunological oncogenic driver mechanism in DLBCL originating from individual BCR sequences and adds a new dimension to currently proposed genetics- and transcriptomics-based DLBCL classifications.
    MeSH term(s) Animals ; Mice ; B-Lymphocytes ; Lymphoma, Large B-Cell, Diffuse/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell ; Receptors, Antigen, B-Cell ; Immunoglobulin M
    Chemical Substances Receptors, Antigen, B-Cell ; Immunoglobulin M
    Language English
    Publishing date 2024-03-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218343-2
    ISSN 1540-9538 ; 0022-1007
    ISSN (online) 1540-9538
    ISSN 0022-1007
    DOI 10.1084/jem.20230941
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Acquisition of a glycosylated B-cell receptor drives follicular lymphoma toward a dark zone phenotype.

    van Bergen, Cornelis A M / Kloet, Susan L / Quinten, Edwin / Sepúlveda Yáñez, Julieta H / Menafra, Roberta / Griffioen, Marieke / Jansen, Patty M / Koning, Marvyn T / Knijnenburg, Jeroen / Navarrete, Marcelo A / Kiełbasa, Szymon M / Veelken, Hendrik

    Blood advances

    2023  Volume 7, Issue 19, Page(s) 5812–5816

    Language English
    Publishing date 2023-07-24
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2023010725
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia.

    Quinten, Edwin / Sepúlveda-Yáñez, Julieta H / Koning, Marvyn T / Eken, Janneke A / Pfeifer, Dietmar / Nteleah, Valeri / De Groen, Ruben A L / Saravia, Diego Alvarez / Knijnenburg, Jeroen / Stuivenberg-Bleijswijk, Hedwig E / Pantic, Milena / Agathangelidis, Andreas / Keppler-Hafkemeyer, Andrea / Van Bergen, Cornelis A M / Uribe-Paredes, Roberto / Stamatopoulos, Kostas / Vermaat, Joost S P / Zirlik, Katja / Navarrete, Marcelo A /
    Jumaa, Hassan / Veelken, Hendrik

    Haematologica

    2024  Volume 109, Issue 3, Page(s) 824–834

    Abstract: Clonal expansion of CD5-expressing B cells, commonly designated as monoclonal B lymphocytosis (MBL), is a precursor condition for chronic lymphocytic leukemia (CLL). The mechanisms driving subclinical MBL B-cell expansion and progression to CLL, ... ...

    Abstract Clonal expansion of CD5-expressing B cells, commonly designated as monoclonal B lymphocytosis (MBL), is a precursor condition for chronic lymphocytic leukemia (CLL). The mechanisms driving subclinical MBL B-cell expansion and progression to CLL, occurring in approximately 1% of affected individuals, are unknown. An autonomously signaling B-cell receptor (BCR) is essential for the pathogenesis of CLL. The objectives of this study were functional characterization of the BCR of MBL in siblings of CLL patients and a comparison of genetic variants in MBL-CLL sibling pairs. Screening of peripheral blood by flow cytometry detected 0.2-480 clonal CLL-phenotype cells per microliter (median: 37/μL) in 34 of 191 (17.8%) siblings of CLL patients. Clonal BCR isolated from highly purified CLL-phenotype cells induced robust calcium mobilization in BCR-deficient murine pre-B cells in the absence of external antigen and without experimental crosslinking. This autonomous BCR signal was less intense than the signal originating from the CLL BCR of their CLL siblings. According to genotyping by single nucleotide polymorphism array, whole exome, and targeted panel sequencing, CLL risk alleles were found with high and similar prevalence in CLL patients and MBL siblings, respectively. Likewise, the prevalence of recurrent CLL-associated genetic variants was similar between CLL and matched MBL samples. However, copy number variations and small variants were frequently subclonal in MBL cells, suggesting their acquisition during subclinical clonal expansion. These findings support a stepwise model of CLL pathogenesis, in which autonomous BCR signaling leads to a non-malignant (oligo)clonal expansion of CD5+ B cells, followed by malignant progression to CLL after acquisition of pathogenic genetic variants.
    MeSH term(s) Humans ; Animals ; Mice ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Siblings ; DNA Copy Number Variations ; Lymphocytosis/genetics ; Leukemia ; Receptors, Antigen, B-Cell/genetics ; Phenotype
    Chemical Substances Receptors, Antigen, B-Cell
    Language English
    Publishing date 2024-03-01
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2333-4
    ISSN 1592-8721 ; 0017-6567 ; 0390-6078
    ISSN (online) 1592-8721
    ISSN 0017-6567 ; 0390-6078
    DOI 10.3324/haematol.2022.282542
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Prognosis of IGLV3-21

    Hengeveld, Paul J / Veelken, Hendrik / van Bergen, Cornelis A M / Quinten, Edwin / Vervoordeldonk, Mischa Y L / Ismailzada, Wahija / Barendse, Rob S / Dubois, Julie M N / van Oers, Marinus H J / Geisler, Christian H / Kater, Arnon P / Westerweel, Peter E / Langerak, Anton W / Levin, Mark-David

    Leukemia

    2023  Volume 37, Issue 9, Page(s) 1929–1932

    MeSH term(s) Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Prognosis
    Language English
    Publishing date 2023-07-21
    Publishing country England
    Document type Letter
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-023-01975-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.

    Koning, Marvyn T / Quinten, Edwin / Zoutman, Willem H / Kiełbasa, Szymon M / Mei, Hailiang / van Bergen, Cornelis A M / Jansen, Patty / Vergroesen, Rochelle D / Willemze, Rein / Vermeer, Maarten H / Tensen, Cornelis P / Veelken, Hendrik

    The Journal of investigative dermatology

    2019  Volume 139, Issue 10, Page(s) 2195–2203

    Abstract: Primary cutaneous follicle center lymphoma (PCFCL) is a rare mature B-cell lymphoma with an unknown etiology. PCFCL resembles follicular lymphoma (FL) by cytomorphologic and microarchitectural criteria. FL B cells are selected for N-linked glycosylation ... ...

    Abstract Primary cutaneous follicle center lymphoma (PCFCL) is a rare mature B-cell lymphoma with an unknown etiology. PCFCL resembles follicular lymphoma (FL) by cytomorphologic and microarchitectural criteria. FL B cells are selected for N-linked glycosylation motifs in their B-cell receptors (BCRs) that are acquired during continuous somatic hypermutation. The stimulation of mannosylated BCR by lectins on the tumor microenvironment is therefore a candidate driver in FL pathogenesis. We investigated whether the same mechanism could play a role in PCFCL pathogenesis. Full-length functional variable, diversity, and joining gene sequences of 18 PCFCL and 8 primary cutaneous diffuse large B-cell lymphoma, leg-type were identified by unbiased Anchoring Reverse Transcription of Immunoglobulin Sequences and Amplification by Nested PCR and BCR reconstruction from RNA sequencing data. Low BCR variation demonstrated negligible ongoing somatic hypermutation in PCFCL and primary cutaneous diffuse large B-cell lymphoma, leg-type, and indicated that the PCFCL microarchitecture does not act as a functional germinal center. Similar to FL but in contrast to primary cutaneous diffuse large B-cell lymphoma, leg-type, BCR genes of 15 PCFCLs (83%) had acquired N-linked glycosylation motifs. These motifs were located at the BCR positions converted to N-linked glycosylation motifs in normal B-cell repertoires with low prevalence but mostly at different positions than those found in FL. The cutaneous localization of PCFCL might suggest a role for lectins from commensal skin bacteria in PCFCL lymphomagenesis.
    MeSH term(s) Aged ; Aged, 80 and over ; Biopsy, Needle ; Cohort Studies ; DNA Mutational Analysis ; Diagnosis, Differential ; Female ; Gene Expression Regulation ; Germinal Center/metabolism ; Glycosylation ; Humans ; Immunohistochemistry ; Lymphoma, Follicular/genetics ; Lymphoma, Follicular/pathology ; Lymphoma, Large B-Cell, Diffuse/genetics ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Middle Aged ; Molecular Sequence Data ; Prognosis ; Receptors, Antigen, B-Cell/genetics ; Skin Neoplasms/genetics ; Skin Neoplasms/pathology ; Tumor Microenvironment/genetics
    Chemical Substances Receptors, Antigen, B-Cell
    Language English
    Publishing date 2019-04-28
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80136-7
    ISSN 1523-1747 ; 0022-202X
    ISSN (online) 1523-1747
    ISSN 0022-202X
    DOI 10.1016/j.jid.2019.04.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study.

    Vianello, Eleonora / Gonzalez-Dias, Patricia / van Veen, Suzanne / Engele, Carmen G / Quinten, Edwin / Monath, Thomas P / Medaglini, Donata / Santoro, Francesco / Huttner, Angela / Dubey, Sheri / Eichberg, Michael / Ndungu, Francis M / Kremsner, Peter G / Essone, Paulin N / Agnandji, Selidji Todagbe / Siegrist, Claire-Anne / Nakaya, Helder I / Ottenhoff, Tom H M / Haks, Mariëlle C

    The Lancet. Microbe

    2021  Volume 3, Issue 2, Page(s) e113–e123

    Abstract: Background: A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to identify ... ...

    Abstract Background: A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to identify transcriptomic immune response biomarker signatures induced by vaccination and associated signatures with its immunogenicity and reactogenicity to better understand the potential mechanisms of action of the vaccine.
    Methods: 354 healthy adult volunteers were vaccinated in randomised, double-blind, placebo-controlled trials in Europe (Geneva, Switzerland [November, 2014, to January, 2015]) and North America (USA [Dec 5, 2014, to June 23, 2015]), and dose-escalation trials in Africa (Lambaréné, Gabon [November, 2014, to January, 2015], and Kilifi, Kenya [December, 2014, to January, 2015]) using different doses of the recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP; 3 × 10
    Findings: Our results indicated that perturbation of gene expression peaked on day 1 and returned to baseline levels between day 7 and day 28. The magnitude of the response was dose-dependent, with vaccinees receiving a high dose (≥9 × 10
    Interpretation: Collectively, our results identify and cross-validate immune-related transcriptomic signatures induced by rVSVΔG-ZEBOV-GP vaccination in four cohorts of adult participants from different genetic and geographical backgrounds. These signatures will aid in the rational development, testing, and evaluation of novel vaccines and will allow evaluation of the effect of host factors such as age, co-infection, and comorbidity on responses to vaccines.
    Funding: Innovative Medicines Initiative 2 Joint Undertaking.
    MeSH term(s) Adult ; Africa ; Antibodies, Viral ; Biomarkers ; Ebola Vaccines/adverse effects ; Ebolavirus/genetics ; Europe ; Glycoproteins/genetics ; Hemorrhagic Fever, Ebola/prevention & control ; Humans ; North America ; Randomized Controlled Trials as Topic ; Transcriptome ; Vesicular Stomatitis/chemically induced ; Vesiculovirus/genetics
    Chemical Substances Antibodies, Viral ; Biomarkers ; Ebola Vaccines ; Glycoproteins
    Language English
    Publishing date 2021-12-06
    Publishing country England
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, Non-U.S. Gov't
    ISSN 2666-5247
    ISSN (online) 2666-5247
    DOI 10.1016/S2666-5247(21)00235-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Retinal Pigment Epithelial Cells Control Early Mycobacterium tuberculosis Infection via Interferon Signaling.

    La Distia Nora, Rina / Walburg, Kimberley V / van Hagen, P Martin / Swagemakers, Sigrid M A / van der Spek, Peter J / Quinten, Edwin / van Velthoven, Mirjam / Ottenhoff, Tom H M / Dik, Willem A / Haks, Mariëlle C

    Investigative ophthalmology & visual science

    2018  Volume 59, Issue 3, Page(s) 1384–1395

    Abstract: Purpose: Mycobacterium tuberculosis (Mtb) bacilli have been found in retinal pigment epithelial (RPE) cells from uveitis patients without signs of systemic tuberculosis (TB) infection. RPE cells are important for ocular immune privilege and uveitis ... ...

    Abstract Purpose: Mycobacterium tuberculosis (Mtb) bacilli have been found in retinal pigment epithelial (RPE) cells from uveitis patients without signs of systemic tuberculosis (TB) infection. RPE cells are important for ocular immune privilege and uveitis development.
    Methods: To address a potential role for Mtb-infected RPE cells in the development of uveitis, we delineated the response to Mtb infection in human RPE cells and primary human macrophages, the main target cell of Mtb. Primary human RPE cells, the human RPE cell line ARPE-19, and monocyte-derived proinflammatory M1 and anti-inflammatory M2 macrophages were infected with DsRed-expressing Mtb strain H37Rv. Infection rates and clearance were addressed along with RNA sequencing analysis, a confirmation analysis by dual-color reverse-transcriptase multiplex ligation-dependent probe amplification (dcRT-MLPA) and cytokine secretion.
    Results: RPE cells robustly controlled intracellular outgrowth of Mtb early after infection. The response in RPE cells to control Mtb survival was dominated by interferon (IFN) signaling and further characterized by prominent regulation of cell death/survival-associated genes and low-level production of Th1-associated cytokines. In contrast, macrophages engaged a plethora of responses including IFN signaling and communication between innate and adaptive immune cells to induce granuloma formation.
    Conclusions: Together, our data demonstrate that RPE cells display a strong response to Mtb infection that appears, however, incomplete in comparison to the macrophage response to Mtb. The RPE response might reflect a balance between mechanisms aimed at Mtb eradication and mechanisms that limit retinal inflammation.
    MeSH term(s) Cells, Cultured ; Cytokines/metabolism ; Epithelial Cells/physiology ; Host-Pathogen Interactions/immunology ; Humans ; Interferon-gamma/metabolism ; Macrophage Activation ; Macrophages/immunology ; Macrophages/microbiology ; Mycobacterium tuberculosis/growth & development ; Mycobacterium tuberculosis/immunology ; Retinal Pigment Epithelium/cytology ; Retinal Pigment Epithelium/immunology ; Retinal Pigment Epithelium/microbiology ; Signal Transduction/physiology ; Tuberculosis, Ocular/immunology ; Tuberculosis, Ocular/microbiology ; Uveitis/microbiology
    Chemical Substances Cytokines ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2018-02-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 391794-0
    ISSN 1552-5783 ; 0146-0404
    ISSN (online) 1552-5783
    ISSN 0146-0404
    DOI 10.1167/iovs.17-23246
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Host Gene Expression Kinetics During Treatment of Tuberculosis in HIV-Coinfected Individuals Is Independent of Highly Active Antiretroviral Therapy.

    Gebremicael, Gebremedhin / Kassa, Desta / Quinten, Edwin / Alemayehu, Yodit / Gebreegziaxier, Atsbeha / Belay, Yohannes / van Baarle, Debbie / Ottenhoff, Tom H M / Cliff, Jacqueline M / Haks, Mariëlle C

    The Journal of infectious diseases

    2018  Volume 218, Issue 11, Page(s) 1833–1846

    Abstract: Background: Limitations in diagnostic tools to discriminate between active tuberculosis and latent Mycobacterium tuberculosis infection and for monitoring antituberculosis treatment responses are major challenges in tuberculosis control, especially in ... ...

    Abstract Background: Limitations in diagnostic tools to discriminate between active tuberculosis and latent Mycobacterium tuberculosis infection and for monitoring antituberculosis treatment responses are major challenges in tuberculosis control, especially in human immunodeficiency virus (HIV)-coinfected individuals.
    Methods: Expression levels of 105 immune-related genes were determined in 131 HIV-infected patients with active tuberculosis (n = 48), patients with latent M. tuberculosis infection (LTBI; n = 37), and controls with no M. tuberculosis infection (n = 46) in Addis Ababa, Ethiopia, using focused gene expression profiling with a dual-color reverse-transcription multiplex ligation-dependent probe amplification assay.
    Results: Within the cohort of HIV-positive subjects, the expression profiles of 7 genes at baseline (FCGR1A, RAB24, TLR1, TLR4, MMP9, NLRC4, and IL1B) could accurately discriminate between active tuberculosis and both latent and no M. tuberculosis infection, largely independently of (in)eligibility for highly active antiretroviral therapy (HAART). Six months after antituberculosis treatment, biomarker profiles of patients with tuberculosis became indistinguishable from those of patients with LTBI and controls. Importantly, host gene expression kinetics during antituberculosis treatment in HIV-coinfected individuals was found to be independent of HAART use.
    Conclusions: Blood transcriptomic profiles can potentially be used as biomarkers to discriminate the different clinical stages of tuberculosis in HIV-coinfected individuals and to monitor tuberculosis treatment responses in both HAART recipients and untreated individuals.
    MeSH term(s) Adult ; Anti-HIV Agents/therapeutic use ; Antiretroviral Therapy, Highly Active/statistics & numerical data ; Biomarkers/analysis ; Coinfection/genetics ; Coinfection/immunology ; Cytokines/analysis ; Cytokines/genetics ; Cytokines/metabolism ; Female ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/genetics ; HIV Infections/immunology ; Humans ; Longitudinal Studies ; Male ; Transcriptome/genetics ; Transcriptome/immunology ; Tuberculosis/complications ; Tuberculosis/genetics ; Tuberculosis/immunology ; Young Adult
    Chemical Substances Anti-HIV Agents ; Biomarkers ; Cytokines
    Language English
    Publishing date 2018-07-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiy404
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Host Immune Responses Differ between M. africanum- and M. tuberculosis-Infected Patients following Standard Anti-tuberculosis Treatment.

    Tientcheu, Leopold D / Haks, Mariëlle C / Agbla, Schadrac C / Sutherland, Jayne S / Adetifa, Ifedayo M / Donkor, Simon / Quinten, Edwin / Daramy, Mohammed / Antonio, Martin / Kampmann, Beate / Ottenhoff, Tom H M / Dockrell, Hazel M / Ota, Martin O

    PLoS neglected tropical diseases

    2016  Volume 10, Issue 5, Page(s) e0004701

    Abstract: Epidemiological differences exist between Mycobacterium africanum (Maf)- and Mycobacterium tuberculosis (Mtb)-infected patients, but to date, contributing host factors have not been characterised. We analysed clinical outcomes, as well as soluble markers ...

    Abstract Epidemiological differences exist between Mycobacterium africanum (Maf)- and Mycobacterium tuberculosis (Mtb)-infected patients, but to date, contributing host factors have not been characterised. We analysed clinical outcomes, as well as soluble markers and gene expression profiles in unstimulated, and ESAT6/CFP-10-, whole-Maf- and Mtb-stimulated blood samples of 26 Maf- and 49 Mtb-HIV-negative tuberculosis patients before, and after 2 and 6 months of anti-tuberculosis therapy. Before treatment, both groups had similar clinical parameters, but differed in few cytokines concentration and gene expression profiles. Following treatment the body mass index, skinfold thickness and chest X-ray scores showed greater improvement in the Mtb- compared to Maf-infected patients, after adjusting for age, sex and ethnicity (p = 0.02; 0.04 and 0.007, respectively). In addition, in unstimulated blood, IL-12p70, IL12A and TLR9 were significantly higher in Maf-infected patients, while IL-15, IL-8 and MIP-1α were higher in Mtb-infected patients. Overnight stimulation with ESAT-6/CFP-10 induced significantly higher levels of IFN-γ and TNF-α production, as well as gene expression of CCL4, IL1B and TLR4 in Mtb- compared to Maf-infected patients. Our study confirms differences in clinical features and immune genes expression and concentration of proteins associated with inflammatory processes between Mtb- and Maf-infected patients following anti-tuberculosis treatment These findings have public health implications for treatment regimens, and biomarkers for tuberculosis diagnosis and susceptibility.
    MeSH term(s) Adolescent ; Adult ; Aged ; Antigens, Bacterial/immunology ; Antitubercular Agents/therapeutic use ; Biomarkers/blood ; Cytokines/blood ; Female ; Gambia ; Gene Expression ; Host-Pathogen Interactions ; Humans ; Interferon-gamma/blood ; Interleukin-5/blood ; Interleukin-8/blood ; Male ; Middle Aged ; Mycobacterium/drug effects ; Mycobacterium/immunology ; Mycobacterium/isolation & purification ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/immunology ; Mycobacterium tuberculosis/isolation & purification ; Tuberculosis/drug therapy ; Tuberculosis/ethnology ; Tuberculosis/immunology ; Tuberculosis/microbiology ; Tumor Necrosis Factor-alpha/drug effects ; Young Adult
    Chemical Substances Antigens, Bacterial ; Antitubercular Agents ; Biomarkers ; Cytokines ; ESAT-6 antigen, Mycobacterium leprae ; IL5 protein, human ; Interleukin-5 ; Interleukin-8 ; Tumor Necrosis Factor-alpha ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2016-05-18
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2429704-5
    ISSN 1935-2735 ; 1935-2735
    ISSN (online) 1935-2735
    ISSN 1935-2735
    DOI 10.1371/journal.pntd.0004701
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.

    Huttner, Angela / Combescure, Christophe / Grillet, Stéphane / Haks, Mariëlle C / Quinten, Edwin / Modoux, Christine / Agnandji, Selidji Todagbe / Brosnahan, Jessica / Dayer, Julie-Anne / Harandi, Ali M / Kaiser, Laurent / Medaglini, Donata / Monath, Tom / Roux-Lombard, Pascale / Kremsner, Peter G / Ottenhoff, Tom H M / Siegrist, Claire-Anne

    Science translational medicine

    2017  Volume 9, Issue 385

    Abstract: The 2014-2015 Ebola epidemic affected several African countries, claiming more than 11,000 lives and leaving thousands with ongoing sequelae. Safe and effective vaccines could prevent or limit future outbreaks. The recombinant vesicular stomatitis virus- ... ...

    Abstract The 2014-2015 Ebola epidemic affected several African countries, claiming more than 11,000 lives and leaving thousands with ongoing sequelae. Safe and effective vaccines could prevent or limit future outbreaks. The recombinant vesicular stomatitis virus-vectored Zaire Ebola (rVSV-ZEBOV) vaccine has shown marked immunogenicity and efficacy in humans but is reactogenic at higher doses. To understand its effects, we examined plasma samples from 115 healthy volunteers from Geneva who received low-dose (LD) or high-dose (HD) vaccine or placebo. Fifteen plasma chemokines/cytokines were assessed at baseline and on days 1, 2 to 3, and 7 after injection. Significant increases in monocyte-mediated MCP-1/CCL2, MIP-1β/CCL4, IL-6, TNF-α, IL-1Ra, and IL-10 occurred on day 1. A signature explaining 68% of cytokine/chemokine vaccine-response variability was identified. Its score was higher in HD versus LD vaccinees and was associated positively with vaccine viremia and negatively with cytopenia. It was higher in vaccinees with injection-site pain, fever, myalgia, chills, and headache; higher scores reflected increasing severity. In contrast, HD vaccinees who subsequently developed arthritis had lower day 1 scores than other HD vaccinees. Vaccine dose did not influence the signature despite its influence on specific outcomes. The Geneva-derived signature associated strongly (ρ = 0.97) with that of a cohort of 75 vaccinees from a parallel trial in Lambaréné, Gabon. Its score in Geneva HD vaccinees with subsequent arthritis was significantly lower than that in Lambaréné HD vaccinees, none of whom experienced arthritis. This signature, which reveals monocytes' critical role in rVSV-ZEBOV immunogenicity and safety across doses and continents, should prove useful in assessments of other vaccines.
    MeSH term(s) Africa ; Ebola Vaccines/adverse effects ; Ebola Vaccines/immunology ; Europe ; Female ; Hemorrhagic Fever, Ebola/blood ; Hemorrhagic Fever, Ebola/immunology ; Humans ; Macrophages/metabolism ; Male
    Chemical Substances Ebola Vaccines
    Language English
    Publishing date 2017-04-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.aaj1701
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top